Disease Management in Ulcer Disease

References

• Boath EH, Blenkinsopp A. The rise and rise of proton pump inhibitor drugs: patients’ perspectives. Soc Sci Med 1997; 45: 1571–9.
   PubMed Web of Science ®Google Scholar
• Martin RM, Lim AG, Kerry SM, Hilton SR. Trends in prescribing H2 receptor antagonists and proton pump inhibitors in primary care. Aliment Pharmacol Ther 1998; 12: 797–805.
   PubMed Web of Science ®Google Scholar
• Newton M, Smith G, Burnham WR, Nocholls C, So B. Hospital use of proton pump inhibitors: a completed audit in the introduction of a prescribing protocol on in-patients prescriptions. Gut 1998; 42 Suppl 1: A69.
   Google Scholar
• Bodger K, Daly MJ, Heatley RV. Clinical economics review: Helicobacter pylori associated peptic ulcer disease. Aliment Pharmacol Ther 1997; 11: 273–82.
   Google Scholar
• Macri G, Milani S, Surrenti E, Passaleva MT, Salvadori G, Surrenti C. Eradication of Helicobacter pylori reduces the rate of duodenal ulcer rebleeding: a long-term follow-up study. Am J Gastroenterol 1998; 93: 925–7.
   PubMed Web of Science ®Google Scholar
• Hirth RA, Fendrick AM, Chernew ME. Specialist and generalist physicians’ adoption of antibiotic therapy to eradicate Helicobacter pylori infection. Med Care 1996; 34: 1199–204.
   Google Scholar
• van der Hulst RWM, Rauws EAJ, Koycu B, et al. Helicobacter reinfection is virtually absent after successful eradication. J Infect Dis 1997; 176: 196–200.
   PubMedGoogle Scholar
• Wilhelmsen I. Quality of life and Helicobacter pylori eradication. Scand J Gastroenterol 1996; 31 Suppl 221: 18–20.
   Google Scholar
• Neil GA, and the Ad Hoc Committee on FDA-Related Matters. Do ulcers burn out or burn on? Managing duodenal ulcer diathesis in the Helicobacter pylori era. Am J Gastroenterol 1997; 92: 387–92.
   Google Scholar
• Fendrick AM, McCort JT, Chernew ME, Hirth RA, Patel C, Bloom BS. Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: clinical and economic effects. Am J Gastroenterol 1997; 92: 2017–24.
   PubMed Web of Science ®Google Scholar
• Veldhuyzen van Zanten SJO. The role of Helicobacter pylori infection in non-ulcer dyspepsia. Aliment Pharmacol Ther 1997; 11 Suppl 1: 63–9.
   Google Scholar
• Megraud F. Transmission of Helicobacter pylori: faecal-oral versus oral-oral route. Aliment Pharmacol Ther 1995; 9 Suppl 2: 85–91.
   PubMedGoogle Scholar
• Sipponen P. Helicobacter pylori gastritis—Epidemiology. J Gastroenterol 1997; 32: 273–7.
   PubMed Web of Science ®Google Scholar
• Roosendaal R, Kuipers EJ, Buitenwerf J, et al. Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol 1997; 92: 1480–2.
   PubMed Web of Science ®Google Scholar
• de Boer WA, van de Wouw BAM, de Vos RJ, Jansz AR, Wijn PFF. Seroprevalence of Helicobacter pylori infection and presence of dyspepsia in military recruits in The Netherlands. In: de Boer WA, Helicobacter pylori. Studies on epidemiology, diagnosis and therapy [Thesis]. University of Amsterdam, 1996. p. 9–16.
   Google Scholar
• Sipponen P, Helske T, Jarvinen P, Hyvarinen H, Seppala K, Siurala M. Fall in prevalence of chronic gastritis over 15 years: analysis of outpatient series in Finland from 1977, 1985 and 1992. Gut 1994; 35: 1167–71.
   PubMed Web of Science ®Google Scholar
• Kosunen TU, Aromaa A, Knekt P, et al. Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect 1997; 119: 29–34.
   PubMed Web of Science ®Google Scholar
• Bardhan PK. Epidemiological features of Helicobacter pylori infection in developing countries. Clin Infect Dis 1997; 25: 973–8.
   PubMed Web of Science ®Google Scholar
• van Nispen CHM, Smout AJPM. Prevalence of Helicobacter pylori in an asymptomatic population in The Netherlands. Eur J Gastroenterol Hepatol 1997; 9: A43–4.
   Google Scholar
• de Boer WA, Wouw van de BAM, Driessen WMM, Jansz AR. Is Helicobacter pylori infection an occupational hazard? A sera epidemiological study among endoscopists. [Abstract]. Neth J Med 1995; 46: A73–4.
   PubMedGoogle Scholar
• Rothenbacher D, Bode G, Winz T, Berg G, Adler G, Brenner H. Helicobacter pylori in out-patients of a general practitioner: prevalence and determinants of current infection. Epidemiol Infect 1997; 119: 151–7.
   PubMedGoogle Scholar
• de Boer WA, Tytgat GNJ. How to treat H. pylori infection. Should treatment strategies be based on testing bacterial susceptibility? Eur J Gastroenterol Hepatol 1996; 8: 709–16.
   Google Scholar
• Huang JQ, Hunt RH. Review: eradication of Helicobacter pylori. Problems and recommendations. J Gastroenterol Hepatol 1997; 12: 590–8.
   PubMedGoogle Scholar
• Wermeille J, Zelger G, Cunningham M. The eradication treatments of Helicobacter pylori. Pharm World Sci 1998; 20: 1–17.
   Google Scholar
• de Boer WA, Tytgat GNJ. The best therapy for Helicobacter pylori infection. Should efficacy or side effect profile determine our choice? Scand J Gastroenterol 1995; 30: 401–7.
   Google Scholar
• Penston JG, Mistry KR. Eradication of Helicobacter pylori in general practice. Aliment Pharmacol Ther 1996; 10: 139–45.
   PubMed Web of Science ®Google Scholar
• Bytzer P, Hansen JM, Scaffalitzky de Muckadell OB. Empirical H2 blocker therapy or prompt endoscopy in management of dyspepsia? Lancet 1994; 343: 811–6.
   Google Scholar
• Numans ME, de Wit NJ, Geerdes RHM, et al. NHG standaard maagklachten (eerste herziening). Huisarts Wet 1996; 39: 565–77.
   Google Scholar
• de Wit NJ, Quartero AO. De plaats van Helicobacter pylori in het beleid bij maagklachten in de huisartsenpraktijk. Huisarts Wet 1997; 40: 233–5.
   Google Scholar
• Bytzer P. Can noninvasive Helicobacter pylori testing save endoscopy? [editorial]. Endoscopy 1997; 29: 649–51.
   PubMedGoogle Scholar
• Vaira D, Stanghellini V, Menegatti M, Palli D, Corinaldesi R, Miglioli M. Prospective screening of dyspeptic patients by Helicobacter pylori serology: a safe policy? Endoscopy 1997; 29: 595–601.
   PubMed Web of Science ®Google Scholar
• Fendrick AM, Chernew ME, Hirth RA, Bloom BS. Immediate endoscopy or initial Helicobacter pylori serological testing for suspected peptic ulcer disease: estimating cost-effectiveness using decision analysis. Yale J Biol Med 1996; 69: 187–95.
   PubMedGoogle Scholar
• Agreus L, Talley N. Challenges in managing dyspepsia in general practice. Br Med J 1997; 315: 1284–8.
   PubMed Web of Science ®Google Scholar
• Lee J, O’Morain C. consensus or confusion: a review of existing national guidelines on Helicobacter pylori-related disease. Eur J Gastroenterol Hepatol 1997; 9: 527–31.
   PubMedGoogle Scholar
• Christie J, Shepherd NA, Codling BW, Valori RM. Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia. Gut 1997; 41: 513–7.
   PubMed Web of Science ®Google Scholar
• Numans ME, Quartero AO. Helicobacter pylori infection [letter]. Lancet 1997; 349: 879.
   PubMedGoogle Scholar
• Foy R, Parry J, Woodman C. Eradication treatment should be limited to patients with proved peptic ulceration. Br Med J 1998; 316: 1244–5.
   Google Scholar
• Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 1442–7.
   PubMed Web of Science ®Google Scholar
• Labenz J, Tillenburg B, Peitz U, et al. Efficacy of omeprazole one year after cure of Helicobacter pylori infection in duodenal ulcer patients. Am J Gastroenterol 1997; 92: 576–81.
   PubMed Web of Science ®Google Scholar
• Chow WH, Blaser MJ, Blot WJ, et al. An inverse relation between Cag A+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998; 58: 588–90.
   PubMed Web of Science ®Google Scholar
• Juul KV, Thomson OO, Nissen A, et al. National surveillance of H. pylori eradication therapy in Denmark: results from registration of 33 310 prescriptions. Gastroenterology 1997; 112:A164.
   Google Scholar
• Hurenkamp GJB, Grundmeyer HGLM, Bindels PJE, Tytgat GNJ, van der Hulst RWM. A population based investigation of long-term acid suppressant use in 24 general practices in The Netherlands [Abstract]. Spring meeting of The Netherlands Society of Gastroenterology 1998.
   Google Scholar
• Ryder SD, O’Reilly S, Miller RJ, Ross J, Jacyna MR, Levi AJ. Long-term acid suppressing treatment in general practice. Br Med J 1994; 308: 827–30.
   PubMed Web of Science ®Google Scholar